Tower Research Capital (TRC)’s Summit Healthcare Acquisition Corp. Class A Ordinary Share SMIH Stock Holding History
Bought
Maintained
Sold
Tower Research Capital (TRC)'s SMIH Position: Q1 2023 in Review
Tower Research Capital (TRC) sold out of Summit Healthcare Acquisition Corp. Class A Ordinary Share (SMIH) in Q1 2023, closing a stake of 8 shares.
Tower Research Capital (TRC) first reported a position in SMIH in Q4 2022 and held it in 1 quarter. The position peaked at $0 in Q4 2022. 0 funds tracked by Wall St. Rank hold SMIH as of Q1 2023.
- Tower Research Capital (TRC) reported no remaining Summit Healthcare Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
- Tower Research Capital (TRC) sold 8 Summit Healthcare Acquisition Corp. Class A Ordinary Share shares in Q1 2023.
- Tower Research Capital (TRC) first reported a position in Summit Healthcare Acquisition Corp. Class A Ordinary Share in Q4 2022 and held it in 1 quarter.
- Tower Research Capital (TRC)'s Summit Healthcare Acquisition Corp. Class A Ordinary Share position peaked at $0 in Q4 2022.
- 0 funds tracked by Wall St. Rank held Summit Healthcare Acquisition Corp. Class A Ordinary Share as of Q1 2023.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.